Skip to content
Research Article Open access CC BY 4.0

Evaluation of the Liver Enzyme (AST, ALT & ALP) Levels of Adult HIV Patients on HAART in UPTH

Chinwe F. Anyanwu, Eric O. Aigbogun Jr., Tosin O. Joseph

Annual Research & Review in Biology · pp. 34–41 · Published 2 May 2020

10.9734/arrb/2020/v35i330198

Abstract

This study evaluated the liver enzyme levels of HIV-infected adult patients on highly active antiretroviral treatment (HAART) for not less than 1 year. The study was designed as a randomised cross-sectional study that evaluated the differences in the aspartate aminotransferase [AST], alanine transaminase [ALT] and alkaline phosphatase [ALP] of 129 (46 males and 83 females) HIV-infected adult patients. Before the study, ethical clearance (Ref: UPH/CEREMAD/REC/19) was obtained from the University of Port Harcourt Ethics Committee. Venous blood samples were obtained and the liver enzyme levels were analysed using Clinical Chemistry Analyser (VS10) manufactured by Vitro Scient. Values were further categorised into; normal or abnormal. SPSS version 21 (IBM® Armonk, USA) and Graph Pad Prism (Version 8.0.2) was used to analyse the data. T-test compared the sex differences in mean, while Chi-square analysis tested the sex differences in the categorised data. From the result, the mean AST (27.65±17.93 IU/L) and ALP (135.13±10.87 IU/L) values for males were higher than females AST (27.25±18.93 IU/L) and ALP (132.65±9.96 IU/L) values, while ALT was higher in female (34.66±22.29 IU/L) than males (33.75±18.14 IU/L); however, the differences were not significant (p>0.05). Generally, abnormal AST, ALT and ALP levels were 31%, 34% and 82% respectively; with no sex-associated differences (p>0.05). 45.7% of the patients (males: 25 [54.3%] and females: 34 [41.0%]) had cholestatic abnormality, while 8.5% (5; 10.9% males and 6; 7.2% females) had hepatocellular abnormality, 18.6% (6; 13.0% of males and 18; 21.7% of females) and mixed abnormality (AST/ALT/ALP). In conclusion, cholestatic abnormalities were observed in more than 80% of the patients as opposed to hepatocellular abnormalities, which were less than 35%. More females were associated with mixed abnormality when compared to males with independent (ALT/AST) abnormality. This study, therefore, suggests the need for a randomised case-control study to highlight the extent of deviation from normal values.

Enzyme levels liver HAART HIV-infected adults sex.

References (22)

  1. 1 Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection [DOI]
  2. 2 Aging and liver disease [DOI]
  3. 3 Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study [DOI]
  4. 4 Upper Limits of Normal for Alanine Aminotransferase Activity in the United States Population [DOI]
  5. 5 Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs [DOI]
  6. 6 Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir [DOI]
  7. 7 The Prevalence and Risk Factors for Abnormal Liver Enzymes in HIV-Positive Patients without Hepatitis B or C Coinfections [DOI]
  8. 8 The declaration of Helsinki: The cornerstone of research ethics
  9. 9 Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania [DOI]
  10. 10 Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.
  11. 11 Hepatotoxicity after introduction of highly active antiretroviral therapy [DOI]
  12. 12 Hepatotoxicity Associated with Antiretroviral Therapy Containing Dual versus Single Protease Inhibitors in Individuals Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus [DOI]
  13. 13 Dyslipidemia in the era of HIV protease inhibitors [DOI]
  14. 14 Pitfalls of Assessing Hepatotoxicity in Trials and Observational Cohorts [DOI]
  15. 15 Acute Liver Failure among Patients on Efavirenz-Based Antiretroviral Therapy [DOI]
  16. 16 Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients [DOI]
  17. 17 Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort [DOI]
  18. 18 Getting to the HAART of insulin resistance [DOI]
  19. 19 Gender difference in the association between aminotransferase levels and hypertension in a Chinese elderly population [DOI]
  20. 20 Effects of HIV Infection and Highly Active Antiretroviral Therapy (HAART) on the Liver of HIV Patients [DOI]
  21. 21 Anti-Retroviral Drug Hepatotoxicity and Risk Factors in HIV Patients with or Without Hepatitis B and C: A Review [DOI]
  22. 22 Evaluating the effects of Moringa oleifera on atherogenic lipoprotein indices of HIV infected Nigerian adults on tenofovir-based antiretroviral regimen [DOI]

Cited by 12

Acute and sub-chronic toxicity studies of methanol extract of Trema orientalis (Linn) blume in albino wistar rats

Omokehinde F. Taiwo, Olubanke O. Ogunlana, Abiodun H. Adebayo · Toxicology Reports · 2024

In Vivo Antimalarial Activity of Trichosanthes cucumerina Against Plasmodium berghei NK65 in Mice

Mohd Shukri Baba, Muhamad Aiman Abd Jalil · Malaysian Applied Biology · 2022

A Comparative of Nutritional Impacts of Pomegranate and Beetroot on Female Mice Bearing Ehrlich Ascites Carcinoma

Dalia Ismaeil Ibrahim Hemdan, Nabila Yahia Mahmoud Abdulmaguid · Archives Of Pharmacy Practice · 2021

Showing 6 of 12 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

59

Page views

0

PDF downloads

18

Outbound clicks

12

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.